Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1020 of 5804
-
New combo therapy targets Hard-to-Treat prostate cancer
Disease control Not yet recruitingThis is a Phase I, open-label, single-center study evaluating the safety, tolerability, and recommended Phase II dose of docetaxel when combined with a fixed dose of 177-Lutetium-PSMA-I\&T in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC)…
Phase: PHASE1 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New stent aims to ease dangerous liver complications
Disease control Not yet recruitingThis Registry will look at patients being treated with a transjugular intrahepatic portosystemic shunt (TIPS) procedure for portal hypertension. The purpose of this Registry is to collect data on the safety and performance of the GORE® VIATORR® TIPS Endoprosthesis with Controlled…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo attack on hard-to-treat myeloma enters human testing
Disease control Not yet recruitingThis study is a prospective, single-arm, multicenter trial designed to evaluate the hematologic response rate and safety of BCMA/CD3 bispecific antibody bridging therapy prior to CAR-T cell infusion in patients with relapsed/refractory multiple myeloma (RRMM).
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Radiation 'Priming' could make lung cancer treatment more effective
Disease control Not yet recruitingThis is a single-center, prospective, open-label, single-arm phase I exploratory study designed to evaluate the safety and feasibility of a novel central immune-priming radiotherapy strategy in patients with unresectable stage III non-small cell lung cancer (NSCLC). The investiga…
Phase: PHASE1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug SKB565 aims to fight advanced solid tumors
Disease control Not yet recruitingThis is a phase I/II clinical study to evaluate the safety and efficacy of SKB565 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Nose ointment may ease Radiation's brutal mouth pain
Symptom relief Not yet recruitingRadiation therapy is a type of treatment that involves using radiation beams targeted at a cancer to destroy the cancer cells or slow their growth. This type of treatment has helped many cancer patients for decades and is intended to kill cancer cells directly. Patients with head…
Phase: PHASE2 • Sponsor: David Palma • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could mounjaro ease heart failure in obesity? new trial investigates
Disease control Not yet recruitingThe central hypothesis to be tested is that patients with obesity and heart failure with preserved ejection fraction (HFpEF) prescribed tirzepatide will demonstrate reductions in measured plasma volume. In conjunction with state-of-the-art body composition analysis and measures o…
Phase: PHASE4 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
AI and footprints: a new way to detect scoliosis?
Diagnosis Not yet recruitingThis study aims to evaluate whether plantar pressure data collected during standing and walking can be used with machine learning to support early detection of scoliosis in young people. Patients with scoliosis and healthy volunteers aged 10-18 will undergo a short assessment usi…
Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
No-Needle breast MRI: AI could replace contrast dye for cancer detection
Diagnosis Not yet recruitingThis study is conducted under the ethics-approved project titled "Artificial Intelligence Solution for Simplifying the Diagnostic Workflow of Breast MRI''.The goal of this observational study is to develop an integrated breast MRI system that uses diffusion-weighted imaging (DWI)…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New device could spot opioid withdrawal in newborns faster
Diagnosis Not yet recruitingThis study will use a new device to measure blood flow and oxygen levels in the brains of newborn infants who have had exposure to opioid medications in the womb, compared to newborns who have not had any exposure.
Phase: NA • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
New combo therapy aims to tackle tough bone cancer
Disease control Not yet recruitingThis is a single-center, single-arm, prospective observational study to evaluate the long-term local control rate, safety, and efficacy of preoperative neoadjuvant radiotherapy (36-45 Gy) followed by sequential radical surgery and postoperative chemotherapy in patients with high-…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New tool may prevent artery blockage during heart valve replacement
Disease control Not yet recruitingThis is a post-market, prospective, multicenter, single-arm post market study sponsored by Pi-Cardia Ltd. The ShortCut is indicated for use as a splitting device of bioprosthetic aortic valve leaflets to facilitate valve-in-valve procedures for subjects at risk for coronary obstr…
Sponsor: Pi-cardia • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a smartphone game ease eating disorder symptoms in young women?
Symptom relief Not yet recruitingThe goal of this clinical trial is to test whether a new digital intervention decreases eating disorder symptoms in young women and girls at risk by changing how they experience thoughts and feelings about their body. The digital intervention is based on Acceptance and Commitmen…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New MRI-Guided brain zaps aim to ease anxiety in days
Symptom relief Not yet recruitingGeneralized Anxiety Disorder (GAD) is a common psychiatric disorder associated with persistent anxiety, functional impairment, and incomplete response to existing treatments. Although transcranial magnetic stimulation (TMS) has shown therapeutic potential in anxiety disorders, co…
Phase: NA • Sponsor: Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New drug cocktail aims at resistant lung cancer
Disease control Not yet recruitingThis single-arm phase II study aims to evaluate the efficacy and safety of lomustine combined with anlotinib in patients with extensive-stage small cell lung cancer resistant to second-line and above systemic treatment.
Phase: PHASE2 • Sponsor: Yayi He • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Gum disease gel could save your teeth
Disease control Not yet recruitingChronic periodontitis is one of the most prevalent inflammatory diseases affecting the tooth-supporting structures and is characterized by progressive clinical attachment loss and alveolar bone resorption resulting from a complex interaction between pathogenic microorganisms and …
Phase: PHASE4 • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New pill aims to bring back color to vitiligo skin
Disease control Not yet recruitingThe purpose of this clinical trial is to learn how well ACT-777991 works, how safe it is and how well it is tolerated by adults with non-segmental vitiligo. The main question this clinical trial aims to answer is: • Can ACT-777991 help return color to the skin of the face of ad…
Phase: PHASE2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
AI eye exam could spot glaucoma in seconds
Diagnosis Not yet recruitingGlaucoma is one of the leading causes of irreversible blindness worldwide. Early diagnosis is crucial to prevent vision loss, but current diagnostic pathways require multiple specialist visits and tests, leading to long waiting times and delayed diagnosis. This study aims to eva…
Phase: NA • Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Home leg exercises may rewire the brain after severe stroke
Knowledge-focused Recruiting nowThe goal of this clinical trial is to determine the effects of home-based cross-education on lower limb neuroplasticity in severe stroke. The main questions the investigators aim to answer are: * What are the effects of home-based cross-education on lower limb neuroplasticity? …
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Rare sinus cancer study aims to clarify treatment outcomes
Knowledge-focused Recruiting nowThis observational study follows patients with T4 stage sinonasal adenoid cystic carcinoma (a rare cancer of the nasal cavity/sinuses) who receive standard treatment: surgery followed by postoperative radiotherapy. The main goal is to measure the 3-year progression-free survival …
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC